These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33109054)

  • 1. Serum Endocan, Neuron-Specific Enolase and Ischemia-Modified Albumin Levels in Newborns with Partial Blood Exchange Transfusion.
    Yarci E; Tayman C; Cakir U; Serkant U
    Comb Chem High Throughput Screen; 2021; 24(6):825-830. PubMed ID: 33109054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.
    Balamir I; Ates I; Topcuoglu C; Turhan T
    Angiology; 2018 Aug; 69(7):609-616. PubMed ID: 29172652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia-Modified Albumin May Be a Novel Marker for Predicting Neonatal Neurologic Injury in Small-For-Gestational-Age Infants in Addition to Neuron-Specific Enolase.
    Tayman C; Öztekin O; Serkant U; Yakut I; Aydemir S; Kosus A
    Am J Perinatol; 2017 Mar; 34(4):349-358. PubMed ID: 27571486
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia.
    Ozek E; Soll R; Schimmel MS
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005089. PubMed ID: 20091569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of neonatal polycythemia and partial exchange transfusion on cardiac function: an echocardiographic study.
    Murphy DJ; Reller MD; Meyer RA; Kaplan S
    Pediatrics; 1985 Dec; 76(6):909-13. PubMed ID: 4069859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocan: A biomarker for endothelial dysfunction and inflammation, linking maternal obesity and pediatric obesity in a cohort of preterm neonates.
    Holthaus E; O'Neill M; Jeske W; DeChristopher P; Goodman J; Glynn L; Levin S; Muraskas J
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():132-137. PubMed ID: 38626514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic neonatal polycythemia: comparison of partial exchange transfusion with saline versus plasma.
    Deorari AK; Paul VK; Shreshta L; Singh M
    Indian Pediatr; 1995 Nov; 32(11):1167-71. PubMed ID: 8772864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia: an important indicator for the application of partial exchange transfusion in polycythemic newborn infants?
    Acunas B; Celtik C; Vatansever U; Karasalihoglu S
    Pediatr Int; 2000 Aug; 42(4):343-7. PubMed ID: 10986862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
    Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
    Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocan - a potential diagnostic marker for early onset sepsis in neonates.
    Zonda GI; Zonda R; Cernomaz AT; Paduraru L; Avasiloaiei AL; Grigoriu BD
    J Infect Dev Ctries; 2019 Apr; 13(4):311-317. PubMed ID: 32045375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hyperviscosity: randomized study of effect of partial plasma exchange transfusion on long-term outcome.
    Black VD; Lubchenco LO; Koops BL; Poland RL; Powell DP
    Pediatrics; 1985 Jun; 75(6):1048-53. PubMed ID: 4000778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased energy expenditure after dilutional exchange transfusion for neonatal polycythemia.
    Dollberg S; Marom R; Mimouni FB; Littner Y
    J Am Coll Nutr; 2007 Oct; 26(5):412-5. PubMed ID: 17914128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of polycythemic newborns: efficacy of partial exchange transfusion.
    Uslu S; Ozdemir H; Bulbul A; Comert S; Can E; Nuhoglu A
    J Matern Fetal Neonatal Med; 2011 Dec; 24(12):1492-7. PubMed ID: 21247234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocan as a marker of disease severity in pulmonary thromboembolism.
    Kuluöztürk M; İn E; İlhan N
    Clin Respir J; 2019 Dec; 13(12):773-780. PubMed ID: 31556240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: effects of partial exchange transfusion with Plasmanate.
    Rosenkrantz TS; Oh W
    J Pediatr; 1982 Jul; 101(1):94-8. PubMed ID: 7086628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial exchange transfusion results in increased cerebral oxygenation and faster peripheral microcirculation in newborns with polycythemia.
    Ergenekon E; Hirfanoglu IM; Turan O; Beken S; Gucuyener K; Atalay Y
    Acta Paediatr; 2011 Nov; 100(11):1432-6. PubMed ID: 21595746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal polycythemia and hyperviscosity.
    Sarkar S; Rosenkrantz TS
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):248-55. PubMed ID: 18424246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism.
    Güzel A; Duran L; Köksal N; Torun AC; Alaçam H; Ekiz BC; Murat N
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):272-6. PubMed ID: 24509328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal polycythemia and hyperviscosity.
    Oh W
    Pediatr Clin North Am; 1986 Jun; 33(3):523-32. PubMed ID: 3714337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum ischemia-modified albumin levels in anemia of prematurity.
    Erol S; Unal S; Demirel N; Kulali F; Isik DU; Aksu U; Bas AY
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3133-3138. PubMed ID: 28783992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.